This study evaluated the health-economic consequences of use of intravenous paricalcitol (Zemplar ®), oral calcitriol or oral and intravenous alfacalcidol for the treatment of patients with ...
Interventions: Oral alendronate 5mg, oral alfacalcidol 1 µg or intranasal calcitonin 200IU daily. Methods: We used the effects on bone mineral density (BMD) in head-to-head trials together with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback